Mental plaque removal

Bart De Strooper () and James Woodgett ()
Additional contact information
Bart De Strooper: Center for Human Genetics, Flanders Interuniversitary Institute for Biotechnology, and the KU Leuven
James Woodgett: Ontario Cancer Institute

Nature, 2003, vol. 423, issue 6938, 392-393

Abstract: Lithium, already used to treat psychiatric disorders, has been found to reduce amyloid-peptide production in a mouse model of Alzheimer's disease. The implication is that lithium's target molecule helps to generate the peptides.

Date: 2003
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/423392a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:423:y:2003:i:6938:d:10.1038_423392a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/423392a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().